merged_eu-covid-vaccines.txt
<other>I need to analyze the article to answer each question based solely on the information provided. I'll go through each question systematically.</other>

<question_number>1</question_number>
<answer>The court ruling casts a shadow on von der Leyen before a crucial vote and gives new momentum to critics, while she needs votes from center-left lawmakers including the Greens who have been incensed by her handling of the coronavirus crisis</answer>

<question_number>2</question_number>
<answer>N/A</answer>

<question_number>3</question_number>
<answer>The Greens have been incensed by the way she handled the coronavirus crisis, affecting her need for their votes in the upcoming confirmation</answer>

<question_number>4</question_number>
<answer>N/A</answer>

<question_number>5</question_number>
<answer>N/A</answer>

<question_number>6</question_number>
<answer>The ruling came just ahead of the tight vote and casts a shadow on von der Leyen before the crucial vote</answer>

<question_number>7</question_number>
<answer>The EU initially had a slow start with a conservative, budget-conscious approach compared to Britain and the US, but later caught up and surpassed other major countries</answer>

<question_number>8</question_number>
<answer>N/A</answer>

<question_number>9</question_number>
<answer>Both involve transparency issues regarding vaccine contracts - the court ruling addresses redacted purchasing agreements while The New York Times case seeks access to text messages between von der Leyen and Pfizer's CEO</answer>

<question_number>10</question_number>
<answer>The lack of transparency on vaccine contracts has contributed to a sense of distrust among European voters about how officials have spent taxpayer money</answer>